HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1403168Generated: November 4, 2026
Diisopropylethylamine → HCID 86686815, compound
https://huagongshe.com/reaction/1403168
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | 4-Amino-1-methylpiperidine | HCID 2737531 | — |
| Reactant | 4-(4-chloro-6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazin-2-yl)morpholine | HCID 22036872 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86686815 | HCID 86686815 | 99.6% |
Reaction Steps
To a solution of 1-methylpiperidin-4-amine (4.6 mg) in N,N-dimethylformamide (200 μL) were added a solution of N,N-diisopropyl ethylamine (8.7 μL) in N,N-dimethylformamide (50 μL) and a solution of 1-[4-chloro-6-(morpholin-4-yl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-1H-benzimidazole (9.2 mg) in N,N-dimethylformamide (300 μL), followed by stirring at 80° C. overnight. To the reaction mixture were added a saturated aqueous sodium bicarbonate solution and chloroform at room temperature, followed by liquid-liquid phase separation, and the organic layer was concentrated under reduced pressure. The residue was purified by preparative HPLC to obtain 4-[2-(difluoromethyl)-1H-benzimidazolyl]-N-(1-methylpiperidin-4-yl)-6-(morpholin-4-yl)-1,3,5-triazin-2-amine (11.1 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08912180B2 |
|---|
| Source dataset | uspto-grants-2014_12 |
|---|
| ORD ID | ord-852cae3ede38431d958f0312a71f0755 |
|---|
| Source note | uspto-grants-2014_12 |
|---|